By Frank Prenesti
Date: Thursday 23 Feb 2023
(Sharecast News) - UK pharma firm GSK's HIV treatment division, ViiV Healthcare, said its HIV injection treatment was as effective as a daily pill made by Gilead Sciences.
Currency | US Dollars |
Share Price | $ 120.98 |
Change Today | $ 0.51 |
% Change | 0.42 % |
52 Week High | $121.83 |
52 Week Low | $72.73 |
Volume | 464,078 |
Shares Issued | 1,246.00m |
Market Cap | $150,741m |
RiskGrade | 120 |
Strong Buy | 10 |
Buy | 11 |
Neutral | 6 |
Sell | 1 |
Strong Sell | 0 |
Total | 28 |
Time | Volume / Share Price |
09:54 | 100 @ $120.98 |
09:54 | 200 @ $121.00 |
09:54 | 101 @ $120.93 |
09:54 | 200 @ $120.96 |
09:53 | 700 @ $120.97 |
You are here: research